ZYME 8-K/A 2026-11-09

Zymeworks Inc. (ZYME) 8-K/A dated 2026-11-09 — accession 0001193125-26-453730.

Zymeworks Inc. (ZYME) is a biotechnology company listed on NASDAQ.

Zymeworks Inc. filed a 8-K/A on 2026-11-09. Accession 0001193125-26-453730.

This 8-K/A covers: Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ZYME revenue for 2025-12-31 was $106.0M. Net income was -$81.1M. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. ZYME currently screens at market cap $1.68B.

Not investment advice. The ZYME SEC hub lists recent forms. The stock page is the research view.